News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KRANZLER JAY D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| KRANZLER JAY D (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 100,000 options to buy
@ $1.14, valued at
$114k
|
|
| 12/21/2021 |
4
| KRANZLER JAY D (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 49,020 shares
@ $0
Granted 20,000 shares
@ $0 |
|
| 06/16/2020 |
4
| KRANZLER JAY D (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 08/28/2019 |
4
| KRANZLER JAY D (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 08/08/2018 |
4
| KRANZLER JAY D (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Gifted 14,663 shares
@ $0 |
|
| 12/29/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2010 |
4
| KRANZLER JAY D (CEO) has filed a Form 4 on CYPRESS BIOSCIENCE INC|
Txns:
| Exercised 152,464 shares
@ $3.25, valued at
$495.5k
Sold 152,464 shares
@ $6.45, valued at
$983.4k
Exercised 152,464 options to buy
@ $3.25, valued at
$495.5k
|
|
| 01/06/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/08/2009 |
4
| KRANZLER JAY D (CEO) has filed a Form 4 on CYPRESS BIOSCIENCE INC |
| 02/04/2009 |
4
| KRANZLER JAY D (CEO) has filed a Form 4 on CYPRESS BIOSCIENCE INC |
| 01/07/2009 |
4
| KRANZLER JAY D (CEO) has filed a Form 4 on CYPRESS BIOSCIENCE INC |
|
|